Results

Total Results: 1,541 records

Showing results for "months".

461. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
     April 06, 2010 - Timing We will include studies if patients have been on the medications for at least 3 months. … the peer review comments are documented and will, for CERs and Technical briefs, be published three months … Type of study □ We excluded articles not written in English, studies less than 3 months in duration,

462. S103 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s103.pdf
     October 01, 2007 - interested in estimating 3-year medical costs, and an individual is lost to follow-up at 2 years and 11 months … inverse probability-weighted estimators require complete data and would exclude those 2 years and 11 months … If data are collected from indi- viduals (eg, at 6 and 12 months), then data in a given interval can

463. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
     January 01, 2014 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Cost- effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results … Revise as shown below: Outcome Results Reported by Authors Minor Bleeding at 12 months Ticagrelor 360 … Bleeding at 3 months was not a primary endpoint. … The numbers shown for composite efficacy endpoint at 30 days and 3 months are for CV death/MI/stroke

464. Head-Neck-Cancer-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
     December 01, 2014 - The literature search for the update was backdated to 12 months before the final literature search … (p=0.008), role functioning at 12 months (p = 0.008), and social contact at 24 months (p=0.03). … a significant benefit (p <0.05) compared with 3DCRT included scales and dry month (6, 12, and 18 months … ), as well as opening mouth (6 and 24 months). … Timing • The relevant periods occur from the time of treatment through followup over months (palliation

465. Dementia-Nursing-Home-Characteristics Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_executive.pdf
     October 01, 2012 - but not clinically, better in settings that used specialized care workers (mean raw change over 6 months … resulted in statistically, but not clinically, better quality of 8 life (mean raw change over 6 months … Low Quality of life Quality of life over 6 months was statistically, but not clinically, significantly … Low Specialized workers vs. not Quality of life over 6 months was statistically, but not clinically … Low Encouraging activities more vs. less Quality of life over 6 months was statistically, but not

466. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
     August 22, 2012 - Medicare Parts A and B (entitlement indicator of “3” and HMO indicator of “0” or “A”) for at least two months … prior to diagnosis and four months post- diagnosis (see Table 1 for population statistics). … We considered cases with a pathology claim within four months of diagnosis with a Health Care Procedure … algorithm used by Liang, et al., to iden- tify HER2 testing in the Medicare claims data within four months … We counted these codes if they ap- peared within four months of diagnosis.

467. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
     January 30, 2013 - www.effectivehealthcare.ahrq.gov Published online: January 30, 2013 5 • Changing the intermediate timeframe to 120 days, 4 months … infection, site pain, abrupt catheter occlusion) • Timing: o Intermediate-term (≤120 days, 4 months … , 16 weeks are the usual time points for the efficacy studies) o Long-term (>120 days, 4 months, 16 … included studies, we will indicate the total number of patients enrolled and longest length (weeks or months … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

468. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - Cancer • New onset diabetes after an organ transplant • Cardiovascular event within the past 3 months … • Timing: o We will include studies if participants are on the medications for at least 3 months … will exclude studies in which the setting observed intervention or exposure period is less than 3 months … fractures; cancer; intermediate outcomes in studies where there was a washout period of less than 3 months … The disposition of comments for systematic reviews and technical briefs will be published three months

469. Tinnitus Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
     August 01, 2013 - A disposition-of-comments report will be made available on the AHRQ Web site 3 months after the posting … However, followup was extended to 12 months in all of the studies evaluating sound-based treatments40,42,43 … and even to 18 months for one study.41 For the psychological and behavioral interventions, many studies … longer term effects (improvement in TSQoL scores) occurred with low-frequency rTMS (1 Hz) at up to 6 months … The influence of training on tinnitus perception: an evaluation 12 months after tinnitus management

470. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
     January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding six months … According to the manufacturer, up to 3 months of data from the device can be logged on the program … Clinical Pathway at Point of This Intervention ASDs can sometimes be detected in individuals at 18 months … Clinical Pathway at Point of This Intervention ASDs can sometimes be detected at 18 months of age or … Clinical Pathway at Point of This Intervention ASDs can sometimes be detected at 18 months of age or

471. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update -- Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-update-surv-rep-2.pdf
     January 01, 2023 - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update -- Surveillance Report 2 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update – Surveillance Report 2 January 2024 Systematic Review: Chou R, Ahmed AY, Morasco BJ…

472. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - We initially interpreted this to mean 6 months or longer, but decided after the abstract screening to … 8 24-26 weeks/6 months 13 10-11 months 2 48 weeks 3 1 year 7 15 months 1 720 days 1 3 … years 3 39 months 1 4 years 2 5 years 1 There was no obvious correlation between study quality … Shibaskaki et al.51 evaluated losartan versus enalapril versus amlodipine over 6 months and reported … An enalapril controlled 3 months study. Nephrol Dial Transplant 1997;12 Suppl 2:19- 23. 47.

473. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding 6 months … statutory declaration from the importer stating that the worms are for personal use and constitute 3 months … During the followup period (up to 25 months) no patient reported dysphagia recurrence, but some patients … treated with teduglutide, and three patients were completely weaned off PN after 6.5, 8, and 9 months … Additionally, after 12 months of treatment with teduglutide, 53% of patients reduced their infusion

474. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
     May 22, 2012 - medication(s), and one trial randomized patients to catheter ablation or cardioversion, followed by 3 months … these trials were single-center studies,22,23 and the followup period in all trials was limited to 12 months …  Restoration of sinus rhythm (conversion)  Maintenance of sinus rhythm  Recurrence of AF at 12 months … o Restoration of sinus rhythm (conversion) o Maintenance of sinus rhythm o Recurrence of AF at 12 months … included studies, we will indicate the total number of patients enrolled and longest length (weeks or months

475. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-centered-medical-home_research-protocol.pdf
     February 23, 2012 - Studies must have at least 6 months’ longitudinal followup. 8 Source: www.effectivehealthcare.ahrq.gov …  For KQs 1-3, published studies of the same type with at least 6 months’ longitudinal followup … stratify the analysis according to length of followup, using the following definitions: short term (6 months … documented and will, for Comparative Effectiveness Reviews (CERs) and Technical Briefs, be published three months

476. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - similar degree, by about 1 absolute percentage point when compared with baseline values, after 3 or more months … difference of about −2.6 kg between metformin and the other drugs, in trials that lasted more than 3 months … and 0 mg/dL to 33 mg/dL for triglycerides [TG]), in studies that generally lasted between 3 and 12 months … pooled between-group difference of 0.07% (95% CI -0.12% to 0.26%) for studies lasting longer than 3 months

477. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - depending on expert comments received on interventions issued for comment during the preceding 6 months … norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant for short-term (3 months … The Reshape Duo is designed to be kept in the stomach for 6 months and then removed, using an endoscopic … with single intragastric balloons.27 The Reshape Duo is designed to be kept in the stomach for 6 months … weight loss.29 In February 2013, the company announced it had completed study enrollment within 6 months

478. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - depending on expert comments received on interventions issued for comment during the preceding 6 months … The Reshape Duo is designed to be kept in the stomach for 6 months and then removed, using an endoscopic … with single intragastric balloons.2 The Reshape Duo is designed to be kept in the stomach for 6 months … weight loss.4 In February 2013, the company announced it had completed study enrollment within 6 months … norepinephrine-releasing drug that FDA approved in 1959 as an appetite suppressant for short-term (3 months

479. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Similarly, denosumab is injected every six months, not once a year. … (Actonel PI, Roux 2004, Sorenson 2003) and alendronate at 12 months (Fosamax PI) The timing of the … It ended early - at 12 months - because of the osteosarcoma rat data that stopped both the male and … The outcome measure was NOT discontinuation for 7 months.

480. AHRQ Slide Template-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
     January 01, 2023 - interval, RoB = risk of bias, RR = relative risk No evidence of difference in hospital readmission by 3 months … Larger box 33 Results – KQ 1: WHEN Healthcare Is Provided (12 studies) 34 Abbreviations: mo = months